SCHEMBL14993411

SCHEMBL14993411

Cc1nc2ccccc2nc1C(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ MAPT P10636 4/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ GPR3 P46089 1/20 0.43
▸ NQO2 P16083 2/20 0.41
▸ HPGD P15428 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ NUDT1 P36639 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ HRH4 Q9H3N8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ PTPN2 P17706 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11327423 0.80 MAPT (0.47) CYP1A2ALDH1A1MAPTKDM4EGPR3
SCHEMBL27809942 0.77 CYP1A2 (0.48) CYP1A2ALDH1A1MAPTKDM4EGPR3
SCHEMBL31003174 0.77 CYP1A2 (0.48) CYP1A2ALDH1A1MAPTKDM4EGPR3
SCHEMBL103601 0.75 MAPT (0.62) CYP1A2ALDH1A1MAPTKDM4EGPR3
SCHEMBL29364974 0.75 MAPT (0.62) CYP1A2ALDH1A1MAPTKDM4EGPR3
Water SCHEMBL27809943 0.75 CYP1A2 (0.47) CYP1A2ALDH1A1MAPTKDM4EGPR3
SCHEMBL27694211 0.75 MAPT (0.50) CYP1A2ALDH1A1MAPTKDM4EGPR3
SCHEMBL29589829 0.74 TDP1 (0.58) CYP1A2ALDH1A1MAPTKDM4ENQO2
SCHEMBL19535296 0.74 TDP1 (0.58) CYP1A2ALDH1A1MAPTKDM4ENQO2
SCHEMBL19535302 0.74 MAPT (0.42) CYP1A2ALDH1A1MAPTKDM4ENQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464087-B2 Difluoromethylation of unsaturated compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-10-11 — — US disclosed
US-9464087-B2 Difluoromethylation of unsaturated compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-10-11 — — US disclosed
US-9464087-B2 Difluoromethylation of unsaturated compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-10-11 — — US disclosed
EP-2785723-B1 DIFLUOROMETHYLATION OF UNSATURATED COMPOUNDS SCRIPPS RESEARCH INST (US) 2016-10-05 — — EP disclosed
EP-2785723-B1 DIFLUOROMETHYLATION OF UNSATURATED COMPOUNDS SCRIPPS RESEARCH INST (US) 2016-10-05 — — EP disclosed
US-20150011760-A1 Difluoromethylation Of Unsaturated Compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-08 — — US disclosed
US-20150011760-A1 Difluoromethylation Of Unsaturated Compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-08 — — US disclosed
US-20150011760-A1 Difluoromethylation Of Unsaturated Compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-08 — — US disclosed
EP-2785723-A1 DIFLUOROMETHYLATION OF UNSATURATED COMPOUNDS The Scripps Research Institute (US) 2014-10-08 — — EP disclosed
WO-2013082028-A1 DIFLUOROMETHYLATION OF UNSATURATED COMPOUNDS THE SCRIPPS RESEARCH INSTITUTE (US) 2013-06-06 — — WO disclosed
WO-2013082028-A1 DIFLUOROMETHYLATION OF UNSATURATED COMPOUNDS THE SCRIPPS RESEARCH INSTITUTE (US) 2013-06-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011760-A1 Difluoromethylation Of Unsaturated Compounds ZRANB2, FDPS, NISCH CYP1A2 1360/4885ALDH1A1 1448/4885MAPT 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback